Advertisement
CNMD vs ZBH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNMD is a StrongBuy and ZBH is a Buy.
CNMD saw its Stochastic Oscillator peaks and leaves the overbought zone
The Stochastic Oscillator for CNMD moved out of overbought territory on November 11, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 60 similar instances where the indicator exited the overbought zone. In 48 of the 60 cases the stock moved lower. This puts the odds of a downward move at 80%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for CNMD moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In 13 of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at 72%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
CNMD broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CNMD entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on CNMD as a result. In 57 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
The Moving Average Convergence Divergence (MACD) for CNMD just turned positive on November 04, 2026. Looking at past instances where CNMD's MACD turned positive, the stock continued to rise in 33 of 47 cases over the following month. The odds of a continued upward trend are 70%.
CNMD moved above its 50-day moving average on November 03, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CNMD crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
Following a +15.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNMD advanced for three days, in 200 of 293 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. CNMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.481) is normal, around the industry mean (4.142). P/E Ratio (27.838) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (11.253). Dividend Yield (0.016) settles around the average of (0.011) among similar stocks. P/S Ratio (1.055) is also within normal values, averaging (40.124).
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ZBH in upward trend: 10-day moving average broke above 50-day moving average on October 26, 2026
The 10-day moving average for ZBH crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on ZBH as a result. In 56 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
The Moving Average Convergence Divergence (MACD) for ZBH just turned positive on October 12, 2026. Looking at past instances where ZBH's MACD turned positive, the stock continued to rise in 27 of 44 cases over the following month. The odds of a continued upward trend are 61%.
ZBH moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZBH advanced for three days, in 196 of 290 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Aroon Indicator entered an Uptrend today. In 126 of 221 cases where ZBH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.
Bearish Trend Analysis
The 10-day RSI Indicator for ZBH moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In 21 of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at 64%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 57 cases where ZBH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 63%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZBH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.
ZBH broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 15 (best 1 - 100 worst), indicating outstanding price growth. ZBH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 24 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.595) is normal, around the industry mean (4.142). P/E Ratio (25.629) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.576) is also within normal values, averaging (11.253). Dividend Yield (0.009) settles around the average of (0.011) among similar stocks. P/S Ratio (2.233) is also within normal values, averaging (40.124).
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZBH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
CNMD | ZBH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 56 | 72 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 62 Fair valued | 67 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 81 | 80 | |
PRICE GROWTH RATING 1..100 | 40 | 15 | |
P/E GROWTH RATING 1..100 | 15 | 24 | |
SEASONALITY SCORE 1..100 | n/a | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CNMD's Valuation (62) in the Medical Specialties industry is in the same range as ZBH (67). This means that CNMD’s stock grew similarly to ZBH’s over the last 12 months.
CNMD's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ZBH (100). This means that CNMD’s stock grew similarly to ZBH’s over the last 12 months.
ZBH's SMR Rating (80) in the Medical Specialties industry is in the same range as CNMD (81). This means that ZBH’s stock grew similarly to CNMD’s over the last 12 months.
ZBH's Price Growth Rating (15) in the Medical Specialties industry is in the same range as CNMD (40). This means that ZBH’s stock grew similarly to CNMD’s over the last 12 months.
CNMD's P/E Growth Rating (15) in the Medical Specialties industry is in the same range as ZBH (24). This means that CNMD’s stock grew similarly to ZBH’s over the last 12 months.
| CNMD | ZBH | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 72% | 1 day ago 64% |
| Stochastic ODDS (%) | 1 day ago 80% | 1 day ago 63% |
| Momentum ODDS (%) | 1 day ago 65% | 1 day ago 65% |
| MACD ODDS (%) | 1 day ago 70% | 2 days ago 61% |
| TrendWeek ODDS (%) | 1 day ago 80% | 1 day ago 57% |
| TrendMonth ODDS (%) | 1 day ago 63% | 1 day ago 57% |
| Advances ODDS (%) | 9 days ago 68% | 15 days ago 68% |
| Declines ODDS (%) | 1 day ago 80% | 7 days ago 54% |
| BollingerBands ODDS (%) | 1 day ago 74% | 1 day ago 55% |
| Aroon ODDS (%) | 1 day ago 76% | 1 day ago 57% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CNMD’s FA Score shows that 1 FA rating(s) are green while ZBH’s FA Score has 2 green FA rating(s).
- CNMD’s FA Score: 1 green, 4 red.
- ZBH’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CNMD’s TA Score shows that 5 TA indicator(s) are bullish while ZBH’s TA Score has 6 bullish TA indicator(s).
- CNMD’s TA Score: 5 bullish, 5 bearish.
- ZBH’s TA Score: 6 bullish, 4 bearish.
Price Growth
CNMD (@Medical/Nursing Services) experienced а -4.45% price change this week, while ZBH (@Medical/Nursing Services) price change was -2.14% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.08%. For the same industry, the average monthly price growth was -5.52%, and the average quarterly price growth was -4.54%.
Reported Earning Dates
CNMD is expected to report earnings on Feb 03, 2027.
ZBH is expected to report earnings on Feb 11, 2027.
Industries' Descriptions
@Medical/Nursing Services (+2.08% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
CNMD and
Correlation & Price change
A.I.dvisor indicates that over the last year, CNMD has been loosely correlated with NVST. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CNMD jumps, then NVST could also see price increases.
| Ticker / NAME | Correlation To CNMD | 1D Price Change % | ||
|---|---|---|---|---|
| CNMD | 100% | -0.57% | ||
| NVST - CNMD | 49% Loosely correlated | -2.61% | ||
| KIDS - CNMD | 49% Loosely correlated | -3.24% | ||
| IART - CNMD | 48% Loosely correlated | -2.84% | ||
| ENOV - CNMD | 47% Loosely correlated | -3.19% | ||
| ZBH - CNMD | 46% Loosely correlated | -2.71% | ||
More | ||||
ZBH and
Correlation & Price change
A.I.dvisor indicates that over the last year, ZBH has been loosely correlated with SNN. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ZBH jumps, then SNN could also see price increases.